Abstract
A docetaxel (DTX) liposomal formulation composed of egg phosphatidylcholine, sodium deoxycholate, and stearylamine was developed. Eudragit (0.5%) was coated to deliver the drug to the region between the distal small intestine and the colon. Lyophilized trehalose and mannitol were used as cryoprotectants because they preserve the particle integrity and good appearance. In vitro release studies showed that the amount of drug released from the coated liposomes was low in solution 1, which simulated the pH condition of the stomach. Especially during the average gastric emptying time, the amount of drug released decreased when Eudragit was added. The plasma DTX concentration was evaluated in pharmacokinetic studies. The plasma drug concentration after intravenous (i.v.) administration decreased rapidly within 120 min. Free DTX formulated using Tween 80 and the lyophilized Eudragit-coated liposomal formulation were compared after oral administration. The oral liposomal formulation had a longer half-life (t1/2) and three-fold higher oral bioavailability. Thus, lyophilized Eudragit-coated liposomal DTX could be a promising therapy for various solid tumors to improve patient convenience and quality of life.
Similar content being viewed by others
References
Aungst BJ (1993) Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci 82:979–987
Barea MJ, Jenkins MJ, Lee YS, Johnson P, Bridson RH (2012) Encapsulation of liposomes within pH responsive microspheres for oral colonic drug delivery. Int J Biomater 2012:458712
Cai Z, Wang Y, Zhu LJ, Liu ZQ (2010) Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Curr Drug Metab 11:197–207
Chaudhury A, Das S, Lee RFS, Tan KB, Ng WK, Tan RBH, Chiu GNC (2012) Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration. Int J Pharm 430:167–175
Choi YH, Han H-K (2018) Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics. J Pharm Investig 48:43–60
Choi M, Shin DH, Kim J (2013) Repositioning of zoledronic acid for breast cancer using transferrin-conjugated liposome. J Pharm Investig 43:461–469
Clarke SJ, Rivory LP (1999) Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet 36:99–114
DeMario MD, Ratain MJ (1998) Oral chemotherapy: rationale and future directions. J Clin Oncol 16:2557–2567
des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V (2006) Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116:1–27
Engels F, Sparreboom A, Mathot R, Verweij J (2005) Potential for improvement of docetaxel-based chemotherapy: a pharmacological review. Br J Cancer 93:173–177
Esmaeili F, Dinarvand R, Ghahremani MH, Amini M, Rouhani H, Sepehri N, Ostad SN, Atyabi F (2008) Docetaxel–albumin conjugates: preparation, in vitro evaluation and biodistribution studies. J Pharm Sci 98:2718–2730
Fricker G, Kromp T, Wendel A, Blume A, Zirkel J, Rebmann H, Setzer C, Quinkert RO, Martin F, Müller-Goymann C (2010) Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res 27:1469–1486
Gao K, Sun J, Liu K, Liu X, He Z (2008) Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. Drug Dev Ind Pharm 34:1227–1237
Grosse P, Bressolle F, Pinguet F (1998) In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-[beta]-cyclodextrin. Eur J Cancer 34:168–174
Guan T, Miao Y, Xu L, Yang S, Wang J, He H, Tang X, Cai C, Xu H (2011) Injectable nimodipine-loaded nanoliposomes: preparation, lyophilization and characteristics. Int J Pharm 410:180–187
Gulati M, Grover M, Singh S, Singh M (1998) Lipophilic drug derivatives in liposomes. Int J Pharm 165:129–168
Hua S (2014) Orally administered liposomal formulations for colon targeted drug delivery. Front Pharmacol 5:138
Huizing M, Misser VHS, Pieters R, ten Bokkel Huinink W, Veenhof C, Vermorken J, Pinedo H, Beijnen J (1995) Taxanes: a new class of antitumor agents. Cancer Investig 13:381–404
Karn PR, Vanic Z, Pepic I, Skalko-Basnet N (2011) Mucoadhesive liposomal delivery systems: the choice of coating material. Drug Dev Ind Pharm 37:482–488
Kato Y, Hosokawa T, Hayakawa E, Ito K (1993) Influence of liposomes on tryptic digestion of insulin. Biol Pharm Bull 16:457–461
Khan MZI, Štedul HP, Kurjakovic N (2000) A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit® L100 and Eudragit S100 combinations. Drug Dev Ind Pharm 26:549–554
Khandare JJ, Jayant S, Singh A, Chandna P, Wang Y, Vorsa N, Minko T (2006) Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjug Chem 17:1464–1472
Kruijtzer C, Beijnen J, Schellens J (2002) Improvement of oral drug treatment by temporary inhibition of drug transporters and/or cytochrome P450 in the gastrointestinal tract and liver: an overview. Oncologist 7:516–530
Kuppens I, Bosch T, Van Maanen M, Rosing H, Fitzpatrick A, Beijnen J, Schellens J (2005) Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093). Cancer Chemother Pharmacol 55:72–78
Lasic DD (1998) Novel applications of liposomes. Trends Biotechnol 16:307–321
Lee SH, Yoo SD, Lee KH (1999) Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography. J Chromatogr B 724:357–363
Liu J, Zahedi P, Zeng F, Allen C (2007) Nano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxel. J Pharm Sci 97:3274–3290
Lyseng-Williamson KA, Fenton C (2005) Docetaxel: a review of its use in metastatic breast cancer. Drugs 65:2513–2531
Ma X, Williams RO (2018) Polymeric nanomedicines for poorly soluble drugs in oral delivery systems: an update. J Pharm Investig 48:61–75
Marchettini P, Stuart AO, Mohamed F, Yoo D, Sugarbaker PH (2002) Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Cancer Chemother Pharm 49:499–503
Nounou MM, El-Khordagui L, Khalafallah N, Khalil S (2005) Influence of different sugar cryoprotectants on the stability and physico-chemical characteristics of freeze-dried 5-fluorouracil plurilamellar vesicles. DARU J Pharm Sci 13:133–142
Okabe T, Terashima H, Sakamoto A (2015) Determinants of liquid gastric emptying: comparisons between milk and isocalorically adjusted clear fluids. Br J Anaesth 114:77–82
O’Sullivan GM, Sutton AJ, Thompson SA, Carrie LE, Bullingham RE (1987) Noninvasive measurement of gastric emptying in obstetric patients. Anesth Analg 66:505–511
Patist A, Zoerb H (2005) Preservation mechanisms of trehalose in food and biosystems. Colloid Surf B 40:107–113
Ringel I, Horwitz SB (1991) Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 83:288–291
Rouini M, Lotfolahi A, Stewart D, Molepo J, Shirazi F, Vergniol J, Tomiak E, Delorme F, Vernillet L, Giguere M (1998) A rapid reversed phase high performance liquid chromatographic method for the determination of docetaxel (Taxotere®) in human plasma using a column switching technique. J Pharm Biomed Anal 17:1243–1247
Rowinsky MEK (1997) The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48:353–374
Russell-Jones G (2001) The potential use of receptor-mediated endocytosis for oral drug delivery. Adv Drug Deliv Rev 46:59–73
Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277:665–667
Shin DH, Xuan S, Kim WY, Bae GU, Kim JS (2014) CD133 antibody-conjugated immunoliposomes encapsulating gemcitabine for targeting glioblastoma stem cells. J Mater Chem B 2:3707–3898
Sinha V, Singh A, Kumar RV, Singh S, Kumria R, Bhinge J (2007) Oral colon-specific drug delivery of protein and peptide drugs. Crit Rev Ther Drug Carrier Syst 24:63
Telang C, Yu L, Suryanarayanan R (2003) Effective inhibition of mannitol crystallization in frozen solutions by sodium chloride. Pharm Res 20:660–667
van Winden ECA, Zhang W, Crommelin DJA (1997) Effect of freezing rate on the stability of liposomes during freeze-drying and rehydration. Pharm Res 14:1151–1160
Voskuhl J, Ravoo BJ (2008) Molecular recognition of bilayer vesicles. Chem Soc Rev 38:495–505
Weiss RB, Donehower R, Wiernik P, Ohnuma T, Gralla R, Trump D, Baker J Jr, Van Echo D, Von Hoff D, Leyland-Jones B (1990) Hypersensitivity reactions from taxol. J Clin Oncol 8:1263–1268
Wils P, Phung-Ba V, Warnery A, Lechardeur D, Raeissi S, Hidalgo IJ, Scherman D (1994) Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. Biochem Pharmacol 48:1528–1530
Yin YM, Cui FD, Mu CF, Choi MK, Kim JS, Chung SJ, Shim CK, Kim DD (2009) Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release 140:86–94
Acknowledgement
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2017R1D1A1B03030849) and the National Research Foundation of Korea (NRF) Grant funded by the Korea Government (MEST, No. 2011-0030074).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Kim, J.H., Shin, D.H. & Kim, JS. Preparation, characterization, and pharmacokinetics of liposomal docetaxel for oral administration. Arch. Pharm. Res. 41, 765–775 (2018). https://doi.org/10.1007/s12272-018-1046-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-018-1046-y